ROYAL BANK OF CANADA - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$017
+6.2%
0.00%
Q2 2023$0
-100.0%
16
-99.9%
0.00%
Q1 2023$37,00020,012
+35635.7%
0.00%
Q4 2022$056
+27.3%
0.00%
Q3 2022$0440.0%0.00%
Q2 2022$0440.0%0.00%
Q1 2022$044
+4.8%
0.00%
Q4 2021$0
-100.0%
42
-70.0%
0.00%
Q3 2021$1,000140
+133.3%
0.00%
Q2 2021$0
-100.0%
60
-78.3%
0.00%
Q1 2021$2,000
+100.0%
276
+142.1%
0.00%
Q4 2020$1,000114
+3700.0%
0.00%
Q3 2020$030.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders